Work

Fecal microbiota transplantation improves anti-PD-1 inhibitor efficacy in unresectable or metastatic solid cancers refractory to anti-PD-1 inhibitor

Year: 2024

Type: article

Study design: Clinical Trial

Source: Cell Host & Microbe

DOI: 10.1016/j.chom.2024.06.010

Authors: Yunjae Kim, Gihyeon Kim, Sujeong Kim, Beomki Cho, Sang-Yeob Kim, Eun-Ju Do, Dong-Jun Bae, Seungil Kim, Mi-Na Kweon, Joon Seon Song, Sang Hyoung Park, Sung Wook Hwang, Mi-Na Kim, Yeongmin Kim, Kyungchan Min, Sung-Han Kim, Mark D. Adams, Charles Lee, Hansoo Park, Sook Ryun Park

Institutions: Gwangju Institute of Science and Technology, Asan Medical Center, University of Ulsan, The Jackson Laboratory for Genomic Medicine

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: GIST Cancer Research Fund, Gwangju Institute of Science and Technology, Ministry of Science, ICT and Future Planning, National Cancer Center, Asan Institute for Life Sciences, Asan Medical Center

Awards: G2271422672, G301214088, G3526084589, G4728117270, G7096541364, G857429818, G8699044126

OpenAlex ID: W4400977720

FWCI: 34.97

Cites: 42

Cited by: 207

Related to: 10